Concert pharmaceuticals, inc. (CNCE)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Assets
Current assets:
Cash and Cash Equivalents, at Carrying Value

46,079

53,043

33,384

43,714

60,262

17,770

39,597

58,359

35,697

27,665

32,119

27,591

28,106

40,555

29,803

53,651

37,821

92,510

20,710

22,567

63,816

13,396

23,436

17,916

39,651

9,638

Investments, available for sale

113,515

53,395

88,165

92,923

93,545

135,544

128,923

121,988

155,305

175,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable equity securities

2,986

5,375

5,435

5,100

5,226

7,525

9,092

9,824

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable equity securities

-

-

-

-

-

-

-

-

9,156

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investments, available for sale

-

-

-

-

-

-

-

-

-

-

174,993

75,829

55,827

55,630

78,189

64,769

89,898

49,680

121,270

129,133

49,251

65,836

66,484

80,413

68,379

23,039

Interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

164

-

-

-

181

-

-

198

262

291

336

317

92

Interest receivable

428

260

291

436

382

556

514

511

580

628

635

218

176

-

323

211

379

-

231

281

-

-

-

-

-

-

Deferred offering costs

0

143

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

1

72

11

38

11

15

144

25

128

155

8

273

17

27

21

133

152

70

136

93

129

1,021

1,245

96

68

170

Income taxes receivable, current

2,358

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract with Customer, Asset, Net, Current

-

-

0

0

0

16,000

16,000

16,000

16,000

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

4,028

4,567

3,830

3,104

2,358

2,739

1,790

2,287

2,597

1,786

1,922

2,318

2,302

1,353

1,432

1,319

2,305

1,667

1,009

1,323

2,241

1,205

1,846

2,204

2,223

1,106

Total current assets

169,395

116,855

131,116

145,315

161,784

180,149

196,060

208,994

219,463

205,734

209,677

106,229

86,428

97,729

109,768

120,083

130,555

144,108

143,356

153,397

115,635

81,720

93,302

100,965

110,638

34,045

Property and equipment, net

7,457

7,753

7,993

8,375

8,640

8,919

8,609

7,698

4,356

2,165

2,111

1,944

2,145

2,199

2,176

2,126

2,248

2,346

2,473

2,372

2,283

2,284

1,975

2,011

2,247

2,473

Restricted cash

1,157

1,157

1,157

1,157

1,157

1,157

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

1,557

1,557

1,557

1,600

400

400

400

400

400

400

400

400

400

400

400

400

400

706

706

706

Other assets

82

96

16

20

22

0

8

16

24

34

41

49

58

67

18

22

92

78

25

34

42

50

59

25

34

2,549

Income taxes receivable

0

2,358

2,358

2,358

2,358

2,322

2,322

2,250

2,246

2,246

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use assets, long-term

9,184

9,252

9,317

9,400

9,400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

187,275

137,471

151,957

166,601

183,391

192,547

208,556

220,515

227,646

211,736

212,229

108,622

89,031

100,395

112,362

122,631

133,295

146,932

146,254

156,203

118,360

84,454

95,736

103,707

113,625

39,773

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

1,444

881

1,302

610

1,613

1,277

1,214

1,084

957

658

481

1,000

1,528

545

1,449

2,402

771

501

1,488

895

1,004

560

1,453

992

1,292

971

Accrued expenses and other liabilities

4,261

8,336

4,434

5,178

4,720

5,669

4,299

3,389

4,200

4,299

3,402

3,909

2,213

3,853

4,236

3,384

3,450

4,772

3,814

3,134

2,704

5,002

4,315

3,612

2,528

2,475

Income taxes payable

0

0

0

0

0

390

-

-

-

46

-

-

-

0

-

-

-

75

-

-

-

0

-

-

-

-

Income taxes payable

-

-

-

-

-

-

418

280

0

-

2,177

-

-

-

0

0

0

-

86

509

-

-

-

-

-

-

Deferred revenue, current portion

7,783

7,783

7,783

1,413

1,413

1,413

1,413

1,413

-

1,442

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability, current portion

783

268

235

202

169

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, current portion

-

-

-

-

-

-

-

-

1,413

-

1,388

1,168

1,159

1,172

1,213

1,221

1,250

1,279

1,455

3,118

5,809

5,955

6,262

6,548

4,741

4,321

Leasehold improvement loan, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

332

Leasehold improvement loan, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

332

332

-

Loan payable, net of discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

775

2,929

5,037

7,101

8,345

8,164

7,987

7,818

Total current liabilities

14,271

17,268

13,754

7,403

7,915

8,749

7,344

6,166

6,570

6,445

7,448

6,077

4,900

5,570

6,898

7,007

5,471

6,627

7,618

10,585

14,554

18,618

20,375

19,648

16,880

15,917

Deferred revenue, net of current portion

2,750

2,750

2,750

9,120

9,120

9,120

9,120

9,120

-

8,859

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, net of current portion

-

-

-

-

-

-

-

-

9,120

-

8,921

8,857

8,874

8,878

8,854

8,867

8,885

8,891

8,886

8,905

9,259

9,866

10,632

11,146

13,950

15,310

Leasehold improvement loan, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

83

166

249

Deferred lease incentive, net of current portion

-

-

-

-

-

4,088

4,202

3,521

846

0

0

84

167

249

331

412

493

573

653

731

810

888

692

128

257

385

Deferred rent, net of current portion

-

-

-

-

-

2,850

2,137

1,425

713

0

0

35

70

104

139

162

184

206

228

238

247

257

260

69

138

208

Lease liability, net of current portion

15,775

15,996

16,190

16,400

16,600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan payable, net of discount

-

-

-

-

-

-

-

-

-

-

-

29,188

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant to purchase redeemable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

463

Loan payable, net of current portion and discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

775

2,930

5,037

7,101

Total liabilities

32,796

36,014

32,694

32,900

33,593

24,807

22,803

20,232

17,249

15,304

16,369

44,241

14,011

14,801

16,222

16,448

15,033

16,297

17,385

20,459

24,870

29,629

32,734

34,004

36,428

39,633

Commitments (Note 11)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Redeemable convertible preferred stock; $0.001 par value per share; 0 and 62,916,667 shares (Series A, B, C, D) authorized, 0 and 56,047,067 shares issued and outstanding in 2014 and 2013, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

112,244

Stockholders’ equity:
Preferred stock, $0.001 par value per share; 5,000,000 shares authorized; no shares issued and outstanding as of March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.001 par value per share; 100,000,000 shares authorized; 29,852,196 and 24,065,676 shares issued and 29,651,595 and 23,865,075 shares outstanding as of March 31, 2020 and December 31, 2019, respectively

29

24

23

23

23

23

23

23

23

23

23

23

22

22

22

22

22

22

22

22

22

18

18

18

18

1

Additional paid-in capital

-

-

-

-

288,156

284,369

-

-

-

273,059

-

-

-

257,461

-

-

-

251,793

-

-

-

200,157

199,378

198,251

197,770

1,528

Additional paid-in capital

369,116

296,145

293,469

290,683

-

-

281,636

278,867

275,810

-

266,081

262,644

260,247

-

255,924

254,601

253,251

-

250,673

249,027

247,800

-

-

-

-

-

Accumulated other comprehensive gain (loss)

492

-31

-35

4

-40

-137

-241

-328

-482

-407

-67

-44

-34

-7

33

43

31

-18

20

-13

6

-14

15

11

-4

4

Accumulated deficit

-215,200

-194,681

-174,194

-157,000

-138,300

-116,515

-95,665

-78,279

-64,954

-76,243

-70,177

-198,242

-185,215

-171,882

-159,839

-148,483

-135,042

-121,162

-121,846

-113,292

-154,338

-145,336

-136,409

-128,577

-120,587

-113,637

Stockholders' Equity Attributable to Parent

154,479

101,457

119,263

133,701

149,798

167,740

185,753

200,283

210,397

196,432

195,860

64,381

75,020

85,594

96,140

106,183

118,262

130,635

128,869

135,744

93,490

54,825

63,002

69,703

77,197

-112,104

Total liabilities and stockholders’ equity

187,275

137,471

151,957

166,601

183,391

192,547

208,556

220,515

227,646

211,736

212,229

108,622

89,031

100,395

112,362

122,631

133,295

146,932

146,254

156,203

118,360

84,454

95,736

103,707

113,625

39,773